SMART assays for tough targets in drug discovery
26 October 2022 – available on demand
SMART assays for tough targets in drug discovery Read More »
Drugging the RNA world at cellular and subcellular levels
24 May 2022 – available on demand
Drugging the RNA world at cellular and subcellular levels Read More »
Trends in natural product Research & Development
11 May 2022 – available on demand
Trends in natural product Research & Development Read More »
Axxam announces the launch of Muna Therapeutics ApS with EUR 60 Million to advance novel small molecule therapeutics for neurodegenerative diseases
Axxam is proud to announce that Muna Therapeutics, a biotech company founded in 2020 by Aarhus University, financed by Novo Seeds and receiving assets in exchange of equity from Axxam, was successful closing a EUR 60 million (US$ 73 million) Series A financing round today.